Search Results - "Sng, Christopher C T"
-
1
Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy
Published in Frontiers in immunology (2024)“…Neoantigens, mutated tumour-specific antigens, are key targets of anti-tumour immunity during checkpoint inhibitor (CPI) treatment. Their identification is…”
Get full text
Journal Article -
2
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience
Published in Frontiers in oncology (20-11-2020)“…The COVID-19 pandemic remains a pressing concern to patients with cancer as countries enter the second peak of the pandemic and beyond. It remains unclear…”
Get full text
Journal Article -
3
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway
Published in Journal of allergy and clinical immunology (01-07-2018)“…Conversely, in both mutant simulations, the distance remained larger, consistent with His41 pointing away from the active site. [...]in addition to disruption…”
Get full text
Journal Article -
4
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
Published in Cancers (08-07-2020)“…We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid…”
Get full text
Journal Article -
5
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
Published in Cancers (02-12-2021)“…An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients…”
Get full text
Journal Article -
6
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
Published in European journal of cancer (1990) (01-08-2022)“…Although SARS-CoV-2 vaccines immunogenicity in patients with cancer has been investigated, whether they can significantly improve the severity of COVID-19 in…”
Get full text
Journal Article -
7
Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score
Published in Clinical cancer research (15-03-2021)“…Abstract We sought to determine parameters of the acute phase response, a feature of innate immunity activated by infectious noxae and cancer, deranged by…”
Get full text
Journal Article -
8
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Published in Journal for immunotherapy of cancer (01-03-2021)“…BackgroundPatients with cancer are particularly susceptible to SARS-CoV-2 infection. The systemic inflammatory response is a pathogenic mechanism shared by…”
Get full text
Journal Article -
9
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
Published in European journal of cancer (1990) (01-06-2021)“…Despite high contagiousness and rapid spread, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected…”
Get full text
Journal Article -
10
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective
Published in Therapeutic advances in medical oncology (2021)“…Background: Specialist palliative care team (SPCT) involvement has been shown to improve symptom control and end-of-life care for patients with cancer, but…”
Get full text
Journal Article